Related Experiment Video
Updated: Jul 15, 2025

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
Three Cases of Myoclonus Secondary to Ciprofloxacin: "Ciproclonus"
Hamna Javed1, Hossam Tharwat Ali2, Ziad Ashraf Soliman2
1Lahore Medical and Dental College, Lahore, Pakistan.
Objectives:
Ciprofloxacin is a fluoroquinolone that is used for bacterial infections involving different systems. In some cases, ciprofloxacin was reported to induce myoclonus.
Methods:
We performed a chart review of 3 patients with myoclonus secondary to ciprofloxacin and reviewed the literature for similar cases. Written consent for publication was obtained from each patient, and their identities were concealed for ethical reasons.
Results:
We describe 3 cases of myoclonus secondary to ciprofloxacin, 2 males and a female aged 61, 26, and 48 years, respectively. The myoclonus appeared within 3 days of ciprofloxacin intake. In all 3 cases, ciprofloxacin was prescribed for urinary tract infection. Electroencephalogram and neuroimaging studies were normal and possible causes were excluded. Thus, ciprofloxacin was believed to be the underlying cause and hence it was withdrawn. The patients had complete recovery on follow-up.
Conclusions:
Although ciprofloxacin is widely prescribed for different infections, only 13 cases were reported to develop myoclonus secondary to ciprofloxacin. The mean age of patients was 62 years. Fifty-four percent of cases were males. Cessation of ciprofloxacin was the most common management course. All individuals fully recovered after ciprofloxacin withdrawal. The mechanism of ciprofloxacin-induced myoclonus is probably associated with γ-aminobutyric acid and glutamate pathways.
Insights
Ciprofloxacin, a common antibiotic, can rarely cause myoclonus (involuntary muscle jerks). Stopping the drug led to full recovery in all reported cases, suggesting a link to neurotransmitter pathways.
Area of Science:
- Neurology
- Pharmacology
- Infectious Diseases
Background:
- Ciprofloxacin is a widely used fluoroquinolone antibiotic.
- Myoclonus is a potential adverse effect of ciprofloxacin therapy.
- Understanding this association is crucial for patient safety.
Purpose of the Study:
- To report cases of ciprofloxacin-induced myoclonus.
- To review existing literature on this adverse event.
- To investigate the clinical characteristics and outcomes.
Main Methods:
- Chart review of three patients experiencing myoclonus after ciprofloxacin use.
- Comprehensive literature search for similar reported cases.
- Exclusion of other potential causes for myoclonus.
Main Results:
- Three cases of myoclonus developed within three days of ciprofloxacin initiation, typically for urinary tract infections.
- Neurological assessments including EEG and neuroimaging were normal.
- Cessation of ciprofloxacin resulted in complete recovery for all patients.
Conclusions:
- Ciprofloxacin is a probable cause of myoclonus in susceptible individuals.
- The mechanism may involve disruption of GABA and glutamate pathways.
- Prompt drug withdrawal is an effective management strategy.
Related Concept Videos
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists

